Literature DB >> 6325107

Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma.

P Attali, D Houssin, A Roche, C Buffet, H Bismuth, J P Etienne.   

Abstract

A patient who presented with hypercalcemia was found to have an hepatocellular carcinoma. Medical treatment failed to normalize blood calcium levels. Liver resection was not feasible due to major extrahepatic involvement. Selective arterial embolization of the tumor was performed, resulting in correction of the hypercalcemia. This observation suggests that some life-threatening complications of unresectable hepatocellular carcinoma can be treated by arterial embolization of the tumor.

Entities:  

Mesh:

Year:  1984        PMID: 6325107     DOI: 10.1007/bf01296226

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Emergency hepatic arterial embolization for secondary hypercalcemia in hepatocellular carcinoma.

Authors:  A Roche; D Franco; D Dhumeaux; H Bismuth; D Doyon
Journal:  Radiology       Date:  1979-11       Impact factor: 11.105

2.  [Hepatic arterial embolisation in neoplastic pathology (author's transl)].

Authors:  A Roche; D Doyon; G Harry; A Weingarten; P Curet
Journal:  J Belge Radiol       Date:  1978

3.  Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.

Authors:  M al-Sarraf; T S Go; K Kithier; V K Vaitkevicius
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

5.  Identification of osteolytic sterols in human breast cancer.

Authors:  G S Gordan; M E Fitzpatrick; W P Lubich
Journal:  Trans Assoc Am Physicians       Date:  1967

6.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

7.  Sclerosing hepatic carcinoma: relationship to hypercalcemia.

Authors:  M Omata; R L Peters; D Tatter
Journal:  Liver       Date:  1981-03

8.  Management of hypercalcemia.

Authors:  E T Zawada; D B Lee; C R Kleeman
Journal:  Postgrad Med       Date:  1979-10       Impact factor: 3.840

9.  Non-operative arterial embolisation in primary liver tumours.

Authors:  P G Wheeler; W Melia; P Dubbins; B Jones; H Nunnerley; P Johnson; R Williams
Journal:  Br Med J       Date:  1979-07-28

10.  Incidence of hypercalcemia and malignant neoplasm.

Authors:  M E Burt; M F Brennan
Journal:  Arch Surg       Date:  1980-06
View more
  2 in total

1.  Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma.

Authors:  K Suzuki; N Kono; A Ono; Y Osuga; H Kiyokawa; I Mineo; Y Matsuda; S Miyoshi; S Kawata; Y Minami
Journal:  Gastroenterol Jpn       Date:  1988-02

2.  Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.

Authors:  Pik Eu Chang; Wai Choung Ong; Hock Foong Lui; Chee Kiat Tan
Journal:  ISRN Oncol       Date:  2013-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.